Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Aug;221(2):95-108.e2.
doi: 10.1016/j.ajog.2019.01.002. Epub 2019 Jan 7.

Two-dose versus single-dose methotrexate for treatment of ectopic pregnancy: a meta-analysis

Snigdha Alur-Gupta  1 , Laura G Cooney  2 , Suneeta Senapati  2 , Mary D Sammel  3 , Kurt T Barnhart  2
Affiliations
Meta-Analysis

Two-dose versus single-dose methotrexate for treatment of ectopic pregnancy: a meta-analysis

Snigdha Alur-Gupta et al. Am J Obstet Gynecol. 2019 Aug.

Abstract

Objective: To compare the treatment success and failure rates, as well as side effects and surgery rates, between methotrexate protocols.

Data sources: PubMed, Embase, and the Cochrane library searched up to July 2018.

Study eligibility criteria: Randomized controlled trials that compared women with ectopic pregnancies receiving the single-dose, two-dose, or multi-dose methotrexate protocols.

Study appraisal and synthesis methods: Odds of treatment success, treatment failure, side effects, and surgery for tubal rupture, as well as length of follow-up until treatment success, were compared using random and fixed effects meta-analysis. Sensitivity analyses compared treatment success in the groups with high human chorionic gonadatropin (hCG) values and a large adnexal mass, as defined by individual studies. The Cochrane Collaboration tool was used to assess risk of bias.

Results: The 2-dose protocol was associated with higher treatment success compared to the single-dose protocol (odds ratio [OR], 1.84; 95% CI, 1.13, 3.00). The 2-dose protocol was more successful in women with high hCG (OR, 3.23; 95% CI, 1.53, 6.84) and in women with a large adnexal mass (OR, 2.93; 95% CI, 1.23, 6.9). The odds of surgery for tubal rupture were lower in the 2-dose protocol (OR, 0.65; 95% CI, 0.26, 1.63), but this was not statistically significant. The length of follow-up was 7.9 days shorter for the 2-dose protocol (95% CI, -12.2, -3.5). The odds of side effects were higher in the 2-dose protocol (OR, 1.53; 95% CI, 1.01, 2.30). Compared to the single-dose protocol, the multi-dose protocol was associated with a nonsignificant reduction in treatment failure (OR, 0.56; 95% CI, 0.28, 1.13) and a higher chance of side effects (OR, 2.10; 95% CI, 1.24, 3.54). The odds of surgery for tubal rupture (OR, 1.62; 95% CI, 0.41, 6.49) and time to follow-up (OR, -1.3; 95% CI, -5.4, 2.7) were similar.

Conclusion: The 2-dose methotrexate protocol is superior to the single-dose protocol for the treatment of ectopic pregnancy in terms of treatment success and time to success. Importantly, these findings hold true in patients thought to be at a lower likelihood of responding to medical management, such as those with higher hCGs and a large adnexal mass.

Keywords: doses; ectopic pregnancy; medical management; methotrexate; protocol; tubal pregnancy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest:

The authors report no conflict of interest.

Figures

Figure 1:
Figure 1:
Flow diagram of study inclusion
Figure 2:
Figure 2:
Risk of bias assessment
Figure 3A:
Figure 3A:
Forest plot: Two versus Single dose-Treatment success
Figure 3B:
Figure 3B:
Forest plot: Two versus Single dose-Treatment failure
Figure 3C:
Figure 3C:
Forest plot: Two versus Single dose-Treatment success in high HCG group (defined by individual studies with a range of >3000–5500 mIUmL)
Figure 3D:
Figure 3D:
Forest plot: Two versus Single dose-Treatment success in large size group (defined by individual studies with a range of >2–3.5cm)
Figure 3E:
Figure 3E:
Forest plot: Two versus Single dose-Side effects
Figure 3F:
Figure 3F:
Forest plot: Two versus Single dose-Surgery for ruptured ectopic pregnancy
Figure 3G:
Figure 3G:
Forest plot: Two versus Single dose-Length of follow-up
Figure 4A:
Figure 4A:
Forest plot: Multi versus Single dose-Treatment failure
Figure 4B:
Figure 4B:
Forest plot: Multi versus Single dose-Treatment success in high HCG group (defined by study as >800 IU/L)
Figure 4C:
Figure 4C:
Forest plot: Multi versus Single dose-Treatment success in large size group (defined by study as >2 cm)
Figure 4D:
Figure 4D:
Forest plot: Multi versus Single dose-Surgery for ruptured ectopic pregnancy
Figure 4E:
Figure 4E:
Forest plot: Multi versus Single dose-Length of follow-up
See this image and copyright information in PMC

Comment in

References

    1. Marion LL, Meeks GR. Ectopic pregnancy: History, incidence, epidemiology, and risk factors. Clin Obstet Gynecol 2012;55:376–86. - PubMed
    1. Hajenius PJ, Mol F, Mol BW, Bossuyt PM, Ankum WM, van der Veen F. Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev 2007:Cd000324. - PMC - PubMed
    1. ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy. Obstet Gynecol 2018;131:e91–e103. - PubMed
    1. Barnhart KT. Clinical practice. Ectopic pregnancy. N Engl J Med 2009;361:379–87. - PubMed
    1. Barnhart K, Coutifaris C, Esposito M. The pharmacology of methotrexate. Expert Opin Pharmacother 2001;2:409–17. - PubMed

Publication types

MeSH terms

Substances